Latest Triple-negative breast cancer Stories
Investment bolsters immediate capital needs for progressing clinical programs SEATTLE, March 10, 2015 /PRNewswire/ -- TapImmune,
WORCESTER, Mass. and TORONTO, Feb.
Clinical Trials for Breast Cancer Vaccine to Begin in 2015 on Florida's First Coast JACKSONVILLE, Fla., Feb.
Nation’s largest cancer magazine reports on beloved television host’s experiences, guidance for others. Plainsboro, NJ (PRWEB) February 05, 2015
Analysis of Phase I Trial indicates Safety and positive immune response data in 21 of 21 patients administered Folate Receptor Alpha Vaccine for breast and ovarian cancers SEATTLE,
SAN ANTONIO, December 11, 2014 /PRNewswire/ -- - The first study in the world combining Reparixin, an oral inhibitor of CXCR1/2, with standard
Studies Using Caris Molecular Intelligence(TM) Identify Standard as well as Novel Therapeutic Options Based on Molecular Characterization of Individual Patients' Tumors IRVING, Texas,
A University of Colorado Cancer Center study being presented at the San Antonio Breast Cancer Symposium shows that triple negative breast cancer cells process tryptophan to promote survival while
Over-expressed gene in triple negative breast cancer offers new diagnostics for risk assessment SINGAPORE, Dec 1, 2014
Results Published in Cancer Epidemiology, Biomarkers & Prevention Demonstrate Utility of Caris Molecular Intelligence(TM) in Exploring Expression of Targetable Immune Proteins IRVING,
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.